Title for MeetingAbstracts
Alphabetical listing of titles
Coping with HIV: a follow-up study of families in Bulawayo, Zimbabwe.
Coping with increasing demand for HIV/AIDS services - franchizing the TASO Model.
Coping with irregular ARV supplies: PLHA experience in Nigeria.
Coping with religious objections to AIDS education.
Coping with success: Lessons from Tanzania and Uganda on managing large scale funding for HIV/AIDS programs.
Coping with the challenges of inadequate funding in running an effective care program for people living with Hiv/Aids.
Coping with the challenges of running an effective care program for PLWAs on minimal funds.
Coping with the Cost of Prescription Medications: Stretched to the Breaking Point?
Coping with the psychological effects of an HIV infection in patients in obstetrics and gynecology.
Coping with the socio-economic impact of AIDS on orphans in Uganda--a search for alternative care and support mechanisms.
Coping with the workload of a mature review group.
Coping, AIDS death and HIV high risk behaviors.
Copper-Silver Ionization System, Water Disinfection and Nosocomial Legionellosis.
Copu de coeur "Operation for a solidarity fund in AIDS sufferers favor.
CORA, a private non-profit association in the area of Health Education with Adolescents (with an emphasis of prevention of pregnancy/STD's and nowadays AIDS/HIV).
Cord blood hCG levels in infants born to HIV positive women: correlation with transmission. American Pediatric Society 104th annual meeting and Society for Pediatric Research 63rd annual meeting; 1994 May 2-5, Seattle.
Cord blood protease inhibitor (PI) concentrations in infants born to mothers receiving PIs.
Cord blood ZDV concentration after intermittent oral administration during labor, Thailand.
Core and comprehensive services in cocaine treatment that impact outcomes.
Core biopsy under ultrasonography is the most cost-effective method for diagnostics of nonpalpable breast lesions.
Core groups cause primary infection to dominate HIV transmission even when more than 90% of virus is excreted during later stages of infection.
Coreceptor preference as a key determinant of pathogenesis by HIV-1 and HIV-2 in lymphoid tissues ex vivo.
Coreceptor trap therapy: combination of CCR5 and CXCR4 inhibitors blocks human immunodeficiency virus type I infection in vivo.
Coreceptor usage by primary HIV-2 isolates.
Coreceptor usage of HIV-1 isolates from children perinatally infected with different HIV-1 subtypes.
Coreceptor use and MT2 tropism of HIV-1 chimeric clones having envelope V3 loop of HIV-1 subtype E.
Coreceptor use in HIV infection of microglial cells.
Coreceptor utilization by divergent human immunodeficiency viruses involves a highly conserved envelope residue.
Coreceptor utilization by HIV-1 isolates that replicate in microglia.
Coreceptor utilization of HIV-1 primary isolates during acute infection.